Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015:2015:517657.
doi: 10.1155/2015/517657. Epub 2015 Dec 30.

Characteristics and Patterns of Metastatic Disease from Chordoma

Victoria A Young  1 , Kevin M Curtis  2 , H Thomas Temple  1 , Frank J Eismont  3 , Thomas F DeLaney  4 , Francis J Hornicek  5
Affiliations

Characteristics and Patterns of Metastatic Disease from Chordoma

Victoria A Young et al. Sarcoma. 2015.

Abstract

Chordoma is a rare, slow-growing malignant tumor arising from notochordal remnants. A retrospective review of patient records at two major referral centers was undertaken to assess the incidence, location, and prognostic factors of metastatic disease from chordoma. 219 patients with chordoma (1962-2009) were identified. 39 patients (17.8%) developed metastatic disease, most frequently to lung (>50%). Median survival from the time of initial diagnosis was 130.4 months for patients who developed metastatic disease and 159.3 months for those who did not (P = 0.05). Metastatic disease was most common in the youngest patients (P = 0.07), and it was 2.5 times more frequent among patients with local recurrence (26.3%) than in those without (10.8%) (P = 0.003). Patient survival with metastatic disease was highly variable, and it was dependent on both the location of the tumor primary and the site of metastasis. Metastasis to distal bone was the most rapid to develop and had the worst prognosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Survival distribution stratified by presence of metastatic disease. Diamonds represent censored data points.
Figure 2
Figure 2
Survival distribution stratified by primary tumor location. Diamonds represent censored data points.
Figure 3
Figure 3
Survival distribution among patients with metastasis stratified by location of metastatic disease. Diamonds represent censored data points.
See this image and copyright information in PMC

References

    1. Healey J. H., Lane J. M. Chordoma: a critical review of diagnosis and treatment. Orthopedic Clinics of North America. 1989;20(3):417–426. - PubMed
    1. Sciubba D. M., Cheng J. J., Petteys R. J., Weber K. L., Frassica D. A., Gokaslan Z. L. Chordoma of the sacrum and vertebral bodies. The Journal of the American Academy of Orthopaedic Surgeons. 2009;17(11):708–717. - PubMed
    1. McMaster M. L., Goldstein A. M., Bromley C. M., Ishibe N., Parry D. M. Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes & Control. 2001;12(1):1–11. doi: 10.1023/a:1008947301735. - DOI - PubMed
    1. Chambers P. W., Schwinn C. P. Chordoma. A clinicopathologic study of metastasis. American Journal of Clinical Pathology. 1979;72(5):765–776. - PubMed
    1. Delank K.-S., Kriegsmann J., Drees P., Eckardt A., Eysel P. Metastasizing chordoma of the lumbar spine. European Spine Journal. 2002;11(2):167–171. doi: 10.1007/s00586-001-0375-5. - DOI - PMC - PubMed